Dianthus Therapeutics (DNTH) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Dianthus Therapeutics (DNTH) over the last 7 years, with Q3 2025 value amounting to -$844000.0.
- Dianthus Therapeutics' Other Gross PP&E Adjustments fell 2120000.0% to -$844000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$844000.0, marking a year-over-year decrease of 2120000.0%. This contributed to the annual value of -$10.3 million for FY2024, which is 5183.22% down from last year.
- Per Dianthus Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$844000.0 for Q3 2025, which was down 2120000.0% from -$921000.0 recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Other Gross PP&E Adjustments ranged from a high of $4000.0 in Q3 2024 and a low of -$25.4 million during Q1 2022
- Moreover, its 4-year median value for Other Gross PP&E Adjustments was -$1.0 million (2025), whereas its average is -$6.6 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first soared by 10093.9% in 2024, then crashed by 2120000.0% in 2025.
- Dianthus Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$915000.0 in 2022, then tumbled by 642.62% to -$6.8 million in 2023, then tumbled by 51.83% to -$10.3 million in 2024, then soared by 91.82% to -$844000.0 in 2025.
- Its last three reported values are -$844000.0 in Q3 2025, -$921000.0 for Q2 2025, and -$1.0 million during Q1 2025.